Brandon Antonakos

1.2k total citations
4 papers, 32 citations indexed

About

Brandon Antonakos is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Computational Theory and Mathematics. According to data from OpenAlex, Brandon Antonakos has authored 4 papers receiving a total of 32 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 1 paper in Pathology and Forensic Medicine and 1 paper in Computational Theory and Mathematics. Recurrent topics in Brandon Antonakos's work include Chromatin Remodeling and Cancer (3 papers), Protein Degradation and Inhibitors (2 papers) and Wnt/β-catenin signaling in development and cancer (1 paper). Brandon Antonakos is often cited by papers focused on Chromatin Remodeling and Cancer (3 papers), Protein Degradation and Inhibitors (2 papers) and Wnt/β-catenin signaling in development and cancer (1 paper). Brandon Antonakos collaborates with scholars based in United States. Brandon Antonakos's co-authors include Nika N. Danial, Joshua M. Korn, Kristen E. Hurov, Yan Yan‐Neale, Mark Stump, Marie Schoumacher, Michael D. Jones, Joseph Lehár, Vesselina G. Cooke and Daisy Flemming and has published in prestigious journals such as Cancer Research, Molecular Cancer Therapeutics and Regular and Young Investigator Award Abstracts.

In The Last Decade

Brandon Antonakos

4 papers receiving 32 citations

Peers

Brandon Antonakos

MB

ONCOL

PFM

CB

IMMUN

Michelle Hu United States

Nusayhah Hudaa Gopee United Kingdom

Azita Rasti Sweden

Hayley R. Hamilton Australia

W Michelle United States

Dominik Vonficht Germany

Lauren E. Bufe United States

Zhiwu Jia China

Michelle Hu United States

Brandon Antonakos

28 ×1.1

MB

9 ×0.9

ONCOL

3 ×0.4

PFM

2 ×0.4

CB

3 ×0.6

IMMUN

Citations per year, relative to Brandon Antonakos Brandon Antonakos (= 1×) peers Michelle Hu

Countries citing papers authored by Brandon Antonakos

Since Specialization

Citations

This map shows the geographic impact of Brandon Antonakos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Antonakos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Antonakos more than expected).

Fields of papers citing papers by Brandon Antonakos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Antonakos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Antonakos. The network helps show where Brandon Antonakos may publish in the future.

Co-authorship network of co-authors of Brandon Antonakos

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Antonakos. A scholar is included among the top collaborators of Brandon Antonakos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Antonakos. Brandon Antonakos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Lee, Janice Y., Nathan A. Brooks, Brandon Antonakos, et al.. (2024). Abstract 3230: Discovery of selective BRM (SMARCA2) ATPase inhibitors for the treatment of BRG1 (SMARCA4) mutant cancers. Cancer Research. 84(6_Supplement). 3230–3230. 1 indexed citations

2.

Lee, Janice Y., Nathan A. Brooks, Brandon Antonakos, et al.. (2024). Abstract PR015: Discovery of LY4050784 (FHD-909), a selective BRM (SMARCA2) ATPase inhibitor for the treatment of BRG1(SMARCA4) mutant cancers. Molecular Cancer Therapeutics. 23(6_Supplement). PR015–PR015. 1 indexed citations

3.

Ichikawa, Kana, Ammar Adam, Hsin‐Jung Wu, et al.. (2022). 888 Synergistic efficacy of the BRM/BRG1 ATPase inhibitor, FHD-286, and anti-PD-1 antibody in mouse syngeneic tumor models. Regular and Young Investigator Award Abstracts. A925–A925. 2 indexed citations

4.

Schoumacher, Marie, Kristen E. Hurov, Joseph Lehár, et al.. (2014). Inhibiting Tankyrases Sensitizes KRAS-Mutant Cancer Cells to MEK Inhibitors via FGFR2 Feedback Signaling. Cancer Research. 74(12). 3294–3305. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact